Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Therapy With or Without Dose Intensified Radiotherapy for Oligo-progressive Disease in Oncogene-addicted Lung Tumours

NCT03256981 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT03256981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03256981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Therapy With or Without Dose Intensified Radiotherapy for Oligo-progressive Disease in Oncogene-addicted Lung Tumours
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 27, 2017
Completion date
June 30, 2025
Enrollment
113 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc